MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Heatmap
  • Русский
  • 中文
  • Español
  • Português
  • 日本語
  • Deutsch
  • 한국어
  • Français
  • Italiano
  • Türkçe
Xilio Therapeutics, Inc. Common Stock

XLO

#4248
Xilio Therapeutics, Inc. - Common Stock
9.0 0 USD
+0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
9.00
9.00
Year Range
0.46
9.90
Daily Change
+0.90%
Monthly Change
+0.45%
6 month change
+1630.77%
Year Change
+1204.35%
Previous Close
8.9 2
Open
9.0 0
Low
9.0 0
High
9.0 0
Volume
1
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. Biotechnology
  5. XLO
Open full chart

Financials

Overview Statement Statistics Documents

2024

Quarterly report, Q2 FY2024
2024.08.08
Xilio Therapeutics, Inc. quarterly report, Q2 FY2024
10-Q
Current report, Q2 FY2024
2024.06.13
Xilio Therapeutics, Inc. current report, Q2 FY2024
8-K
Current report, Q2 FY2024
2024.06.17
Xilio Therapeutics, Inc. current report, Q2 FY2024
8-K
  • 1
  • 2
  • 3
  • 4
  • 5

News

Zacks
AZN NVS JNJ PFE VSTM
2026.05.18
Cancer Stocks That Are Advancing the Future of Oncology Care
Zacks
XLO KMDA
2026.05.12
Xilio Therapeutics, Inc. (XLO) Reports Q1 Loss, Beats Revenue Estimates
Zacks
XLO
2026.05.12
Opus Genetics, Inc. (IRD) Reports Q1 Loss, Misses Revenue Estimates
Zacks
OCS XLO
2026.05.11
Oculis Holding AG (OCS) Reports Q1 Loss, Lags Revenue Estimates
Zacks
XLO
2026.04.01
Xilio Therapeutics (XLO) Upgraded to Buy: What Does It Mean for the Stock?
Zacks
XLO
2026.04.01
Xilio Therapeutics (XLO) Upgraded to Buy: What Does It Mean for the Stock?
Zacks
AZN NVS JNJ PFE MRK
2026.03.26
Cancer Stocks to Buy as Innovation Reshapes Global Oncology Market
Investing
XLO
2026.03.12
Xilio Therapeutics implements 1-for-14 reverse stock split
Investing
XLO
2026.01.08
Xilio Therapeutics secures $35.8 million from warrant exercises
Investing
XLO
2025.11.13
Xilio Development earnings missed by $0.06, revenue topped estimates
Zacks
XLO IMTX
2025.11.13
Xilio Therapeutics, Inc. (XLO) Reports Q3 Loss, Misses Revenue Estimates
Zacks
BTAI XLO
2025.11.12
BioXcel Therapeutics, Inc. (BTAI) Reports Q3 Loss, Misses Revenue Estimates

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Store
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stocks
  • Metals
MetaTrader 5
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
MQL5 Channels
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Economic Calendar
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Subscribe to algo trading news
Risk Disclosure Terms of Use Help Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd